Thu, Jul 10, 2014, 12:42 PM EDT - U.S. Markets close in 3 hrs 18 mins

Recent

% | $
Quotes you view appear here for quick access.

Isis Pharmaceuticals, Inc. Message Board

jetmanbash 93 posts  |  Last Activity: Jul 1, 2014 10:29 PM Member since: Dec 29, 2004
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Matt BerryBashWang Has STOCKholm Syndrome...

    by aniustudent May 22, 2014 10:18 AM
    jetmanbash jetmanbash May 28, 2014 9:32 AM Flag

    There might be a food fight at the AEGR headquarters soon. And Greg(Mr. Beer) did the dirty deed so the FDA may take him down. Look for that to maybe happen Stork. t

  • Reply to

    Matt BerryBashWang Has STOCKholm Syndrome...

    by aniustudent May 22, 2014 10:18 AM
    jetmanbash jetmanbash May 27, 2014 9:23 PM Flag

    You are dodging the question. And changing if, you worked for ISIS and you don't know the answer to that simple question. Keep watching, and accusing and let's see where we go. JC stated that he was happy to get in at that very low price of $42, not so much maybe now at almost a new low for the year. Mr. Beer has gone into his tool box(toy box for him) with his purchase of shares that he sold at 80 and now buying back some in the 30"s. A hero move after he really messed the company up. t

  • jetmanbash jetmanbash May 27, 2014 9:17 PM Flag

    Halt-the-Rancor, you are quite the arrogant fellow. GS made a huge mistake and you know all the variables as to why they made that decision? ZAP3 still coming and the stock is caving in before it is even here. GS has many more reliable resources than you do. We'll have to see. You have all of this anger because you bought this stock and thought you could sit on the couch will the money just rolled in up to 1200 per share. Look in the mirror before you call GS anything. t

  • jetmanbash jetmanbash May 26, 2014 6:54 PM Flag

    I could make the same argument that you, Yugo, halt-the-self-centered-ranger are the same person but I won't. Yugo wrote like Young Frankenstien, the HSCR is is really arrogant with no real knowledge, and you are at least nicer while you insult someone. You still don't know the those initials, and you don't know what awaits you with this one med company. This is not QCOR, though Mr. Beer would like you to think it is. Mr. Beer did it again, this in regards to directing conversations that aren't asked. He said that AEGR isn't looking to be bought out. Usually when you bring that up unasked it usually means that they are looking to be bought out. Kind of like the politician saying that he isn't going to bring up his opponents affair during this campaign. Problem for AEGR is that this isn't any QCOR with multiple indications. This company is wound together with binder twine. We'll see how things go. Instead of the HSCR trying to arrest us he should have listened. Don't need a pledge pin to do that. t

  • jetmanbash jetmanbash May 26, 2014 5:59 PM Flag

    No real ability to respond so we get a second grader with the over played prune juice thing. You're going to get more and more jealous as time goes on because things are gong to get more and more out of hand and against your wishes. t

  • Reply to

    Matt BerryBashWang Has STOCKholm Syndrome...

    by aniustudent May 22, 2014 10:18 AM
    jetmanbash jetmanbash May 26, 2014 5:44 PM Flag

    You are a funny person. The CA risks with AEGR's drug have really been higher. Their other risks will also be shown to be higher. You are again lying as there has been no proof about any same location thing. People will eventually figure out you are lying as the writing styles are different and people can't generally continue to keep up with those different writing skills. Waiting of the initials of the head of toxicology over at ISIS. t

  • Reply to

    Cramer says everyone should own Isis

    by outtinfront May 24, 2014 8:45 AM
    jetmanbash jetmanbash May 26, 2014 2:23 PM Flag

    You definitely never worked at ISIS and you have been very wrong yourself in regards to your buy recommendation timing for AEGR you champion of stocks. t

  • Reply to

    Matt BerryBashWang Has STOCKholm Syndrome...

    by aniustudent May 22, 2014 10:18 AM
    jetmanbash jetmanbash May 23, 2014 12:02 AM Flag

    You also are a liar as you never worked at ISIS and you don't know the initials of the head of toxicology. And you are confused. You don't like the management but you love the stock.......kind of violates stock investing 101. Good luck with your tweener strategy. t

  • Reply to

    Enough Already

    by vvusforme71 May 14, 2014 8:43 AM
    jetmanbash jetmanbash May 22, 2014 11:59 PM Flag

    You are funny and a liar. I had advised several people not to short this stock as I knew it would be glamorized by wall street and I knew the ways of Mr. Beer like when he raised the price of the drug due........to demand. Neidemier for being a ranger you should turn yourself in or change your name to:stop-it's-the-liar. t

  • jetmanbash jetmanbash May 22, 2014 8:25 AM Flag

    Way too much good news coming down the road to hold this company back. The GCGR inhibitor and this Factor XI inhibitor both have blockbuster potential. You then have their TTR-amyloidosis inhibitor, their ApoCIIII inhibitor, the STAT3. Inhibitor, and 25 other drugs. Also, the real reason AEGR is in their malaise is because Mipo is taking market share from them and with their one shot on goal they are starting to get closed in. t

  • Reply to

    Why $ISIS Continues to Fall...

    by aniustudent May 21, 2014 3:52 PM
    jetmanbash jetmanbash May 22, 2014 12:48 AM Flag

    I think you are a liar and you never worked at ISIS like you've claimed. Your mad because your investment in AEGR is in fire with NO other shots on goal. Just ISIS GCGR inhibitor will be worth more than all of AEGR. BTW the CEO is trying to bail himself out with investors by buying another 10,000 shares today. He is already down over $120K on his recent purchase of 30K shares. t

  • Reply to

    Analyst 12 Month Price Targets

    by vvusforme71 May 14, 2014 2:47 PM
    jetmanbash jetmanbash May 16, 2014 1:07 AM Flag

    Yugo $1200

  • jetmanbash jetmanbash May 14, 2014 8:42 PM Flag

    All good and valid points. This is a very high risk investment that has become even riskier with Mr. Beer at the helm. At the beginning of the year they had the risk of a 20 year old drug held together with a cotton candy patent. They now have risks of running out of money before they can really make a profit. They have ONE shot on goal and that is it. I wouldn't count on Germany changing their stance, and I wouldn't count on the companies goal of having no country undersell the price in the US by more than 20%. t

  • Reply to

    Why up almost a dollar after hours?

    by rationalranger May 9, 2014 10:52 PM
    jetmanbash jetmanbash May 13, 2014 12:51 PM Flag

    I have to say, reading your last line it borders on a little bit of arrogance there. Throw in the lawyer bit and you maybe never being wrong and it really sets up for some dynamic movement. t

  • Reply to

    Why up almost a dollar after hours?

    by rationalranger May 9, 2014 10:52 PM
    jetmanbash jetmanbash May 13, 2014 9:16 AM Flag

    You are getting me mixed up with halt-the-ranger as I've never played the insider info card. I doubt the ranger will arrest you as you are one of the good guys on his side. This company is not JAZZ, nor is it GILD, and in fact I don't believe it is any of those that you've listed. Time will tell. t

  • Reply to

    SINGLE DIGIT not rule out..ISIS

    by listen_jockers May 9, 2014 9:47 PM
    jetmanbash jetmanbash May 13, 2014 5:04 AM Flag

    I know VICL is worth only about a buck and some change going toward BK. But you don't know how good it makes me feel to.know that there is a medication at there, thanks to them, that would allow me to treat my dog should he get melanoma of the mouth.......just like having an insurance policy. t

  • jetmanbash jetmanbash May 12, 2014 11:24 PM Flag

    Look for my success and ISIS to right back up. Their satalitte company had good news today in a leer reviewed journal for their eye drops:
    Aganirsen antisense oligonucleotide eye drops inhibit keratitis-induced corneal neovascularization and reduce need for transplantation: The I-CAN study
    Ophthalmology, 05/12/2014  Clinical Article
    Cursiefen C, et al. – The authors aimed to confirm the results of phase II study, in this multicenter, double–masked, randomized, placebo–controlled phase III study and investigated a potential clinical benefit on visual acuity (VA), quality of life (QoL), and need for transplantation. Results showed that aganirsen eye drops significantly inhibited corneal neovascularization in patients with keratitis and the need for transplantation was significantly reduced in patients with viral keratitis and central neovascularization. Thus, topical application of aganirsen was safe and well tolerated.

  • Reply to

    just bought another 39k at 0.81

    by anacondachaser May 9, 2014 12:53 PM
    jetmanbash jetmanbash May 9, 2014 9:45 PM Flag

    The company is moving methodically ahead. I think they have potential from their three drugs, but also their pipeline, and their delivery system that could take a lot of old generic CA drugs and turn them into new high class winners. There could be a win-win-win situation. The patient would get a better chance at getting cured or better, the insurance carrier could actually save money in not having to pay for so many side-effects and adverse reactions in treatment for them, and RNN could really flourish. I think it will happen. t

  • Reply to

    Hey look, ArthurDikLik is back

    by halt_the_ranger May 7, 2014 12:40 AM
    jetmanbash jetmanbash May 8, 2014 11:46 PM Flag

    Instead of saying thank you for pointing out the fact that maybe I might not have all of the facts you continued to denigrate both A1, myself and others. You remind me a lot of Neidimeir on the movie Animal House and your horse just got hit by a golf ball.........enjoy the ride, and I don't have a pledge pin Neidimeir. t

  • http://finance.yahoo.com/news/genzyme-isis-receive-corporate-award-130000849.html

ISIS
30.56-0.35(-1.13%)12:41 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.